Many countries in the Americas have detected local transmission of multiple arboviruses that cause febrile illnesses. Therefore, laboratory testing has become an important tool for confirming the etiology of these diseases. The present study aimed to compare the sensitivity and specificity of three different Zika virus detection assays. One hundred serum samples from patients presenting with acute febrile symptoms were tested using a previously reported TaqMan ® RT-qPCR assay. We used a SYBR ® Green RT-qPCR and a conventional PCR methodologies to compare the results. Of the samples that were determined to be negative by the TaqMan ® RT-qPCR assay, 100% (Kappa = 0.670) were also found to be negative by SYBR ® Green RT-qPCR based on Tm comparison; however, 14% (Kappa = 0.035) were found to be positive by conventional PCR followed by agarose gel electrophoresis. The differences between the ZIKV strains circulating worldwide and the low viremia period can compromise diagnostic accuracy and thereby the accuracy of outbreak data. Therefore, improved assays are required to improve the diagnosis and surveillance of arbovirus.
Introduction
Many countries in the Americas have detected local transmission of multiple arboviruses that cause febrile illnesses accompanied by rash, myalgia, or arthralgia. Therefore, laboratory testing has become an important tool for confirming the established by testing patient serum to detect viral nucleic acid or virus specific immunoglobulins and neutralizing antibodies. 2 However, serological cross-reactivity may occur between ZIKV and other flaviviruses (DENV, yellow fever virus, St. Louis encephalitis virus, Japanese encephalitis virus, and West Nile virus). Hence, emphasis should be placed on molecular diagnostic assays (e.g., RT-PCR) for acute specimens collected from individuals with clinically compatible illnesses. [3] [4] [5] [6] The current diagnostic tests for ZIKV have several limitations. 7 Therefore, this work aimed to compare the sensitivity and specificity of the previously reported TaqMan ® RT-qPCR for ZIKV detection 5 with those of SYBR ® Green RTqPCR, and conventional PCR.
Material and methods

Sample collection
A total of 100 serum samples from patients presenting with acute febrile disease for ≤5 days from January to May 2016 were tested for ZIKV infection by TaqMan ® RT-qPCR, 5 
Sample preparation
Blood samples were collected, and the sera were separated and stored at −80 • C. Viral RNA was extracted from 140 L of each serum using the QIAamp Viral RNA Mini kit (QIAGEN, Germany) according to the manufacturer's instructions, and the RNAs were tested by the various PCR-based assays.
ZIKV detection by TaqMan
®
The RNA was initially tested for ZIKV by a TaqMan ® RTqPCR, as previously described, 5 using the GoTaq ® Probe
1-
Step RT-qPCR System (Promega). The same samples were also screened for DENV and CHIKV by Multiplex-nested-PCR 8 and RT-qPCR 9 respectively. The qPCRs were performed using the Thermocycler StepOne Real-Time PCR System (Applied Biosystems) and the multiplex-nested-PCR was performed using the Veriti 96 well Thermal Cycler (Applied Biosystem). 
ZIKV detection by SYBR
ZIKV detection by conventional PCR
To perform the conventional PCR, four primers targeting the ZIKV NS5 protein were designed. The primers were based on infectious clones from the African ZIKV strains (GenBank accessions LC002520. PCR products were loaded onto a 1.5% agarose gel and visualized under ultraviolet light. Amplicon sizes were determined by comparison with a 100 bp DNA ladder (Invitrogen). Precautions to avoid contamination were taken; positive (Zika virus strain MR 766) and negative (water + all PCR components) controls were used in all reactions/amplification protocols, and the procedure was repeated 3 times. 10 
Statistical analyses
The accuracy of any diagnostic method can be determined by calculating its positive predictive value (PPV) and negative predictive value (NPV). The effect of prevalence on predictive values was calculated according to Bayes's theorem. 11 Differences in the results of the tests were assessed using Fisher's exact test 12, 13 and Kappa test. 14 The confidence interval of the estimates was computed using the 'exact method' developed by Clopper and Pearson (GraphPad Prism package 2.01; Graph-Pad).
Results
We selected 100 serum samples collected between January and May 2016 from patients with suspected cases of ZIKV disease, based on the presence of macular or papular rash with two or more of the following signs and symptoms: fever or conjunctival hyperemia without secretion and pruritus, polyarthralgia or joint edema. Of these, 59 samples (59%) were determined positive (Ct < 38.5) and 41 samples (41%) were determined negative (Ct > 38.5) using TaqMan ® RT-qPCR. 5 The sensitivity and specificity of the methodology were compared with those of other laboratory methods (SYBR ® Green RT-qPCR and conventional PCR) ( Table 1) . From the samples that were found to be negative by TaqMan ® RT-qPCR, 41 (100%) (Kappa = 0.670) were also found to be negative by SYBR ® Green RT-qPCR based on Tm comparison (Supplementary Table S1 ), but 6 (14%) (Kappa = 0.035, p < 0.0001) were found to be positive by conventional PCR followed by agarose gel electrophoresis (Fig. 1) . To confirm the results, the 6 positive samples were inoculated on Vero cells. RNA was extracted and ZIKV identification was performed by a TaqMan ® RT-qPCR, as previously described. 5
Discussion
ZIKV, which emerged after DENV and CHIKV in the city of São José do Rio Preto, represents a new public health concern in this region, and continues to be misdiagnosed. 15 Laboratory diagnosis of acute ZIKV infection currently relies upon the detection of ZIKV RNA in biological fluids include serum, plasma, urine, saliva, and amniotic fluid. 16 The ability of RT-PCR to detected of ZIKV RNA in blood is limited, because ZIKV viremia is usually low and limited to the third and fourth day after disease onset. 5 Future studies with larger numbers of positive specimens will be required to further characterize the dynamics of ZIKV levels in blood and to determine whether virus load is correlated with disease severity and immune responses. 16 Accurate diagnosis of acute ZIKV infection may require testing of multiple specimen types. According to the literature, the mean days of illness were not significantly different between patients with ZIKV RNA detectable only in the saliva and those with ZIKV RNA detectable only in the serum. 16, 17 Higher ZIKV RNA loads are detectable in the urine and semen after longer periods (10-20 and 27-62 days after onset of symptoms, respectively), suggesting that the detection of the ZIKV RNA in other specimen types could be a potential alternative diagnostic technique. 4, 18 The current diagnostic tests for ZIKV includes the conventional one-step RT-PCR assay targeting the E gene 19, 20 and the nonstructural proteins 1 (NS1), 20 3 (NS3) 21 and 5 (NS5), 5 respectively. A previous genetic study using nucleotide sequences derived from the NS5 gene indicated three ZIKV lineages: East African, West African, and Asian. 5 Genetic analyses have revealed close relationships between the virus strains in the South American and Pacific Island outbreaks, suggesting that the Pacific islands may have been the springboard for the South American epidemic. 22, 23 The sequences of these strains are different from those used for the detection of ZIKV, which were designed by the CDC using primer/probe sets based on ZIKV MR766 GenBank accession no. AY632535 (country: Uganda). 5 Interestingly, in the present study, the Brazilian samples (Asian lineage) were negative for ZIKV in the TaqMan ® RT-qPCR and SYBR ® Green RT-qPCR assay, whereas 12% of the samples were positive for ZIKV in the conventional PCR assay; for both methodologies, primers based on African ZIKV isolates were used.
In addition to the benefits common to any qPCR reaction, the statistical parameters (Kappa = 0.670) prove optimized SYBR Green method has similar performances to TaqMan method and data analysis was show with the help of high performance primer designing software and by utilization proper protocols and material we can achieve high quality and precise data by SYBR Green as the TaqMan method. 24 Future work will involve reducing the limitations of current diagnostic tests for ZIKV. As this pandemic evolves, further development, evaluation, and widespread implementation of ZIKV diagnostics will be critical to monitoring, preventing, and treating Zika fever.
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